109 related articles for article (PubMed ID: 16540168)
1. Successful treatment of multi-agent chemotherapy with rituximab for IgM plasma cell leukemia.
Oka S; Yokote T; Akioka T; Hara S; Yamano T; Tsuji M; Hanafusa T
Leuk Res; 2006 Dec; 30(12):1581-3. PubMed ID: 16540168
[TBL] [Abstract][Full Text] [Related]
2. [Effective measurement of coronary flow velocity reserve (CFVR) with transthoracic Doppler echocardiography (TTDE) for plasma cell leukemia with hyperviscosity syndrome].
Oka S; Yokote T; Akioka T; Hara S; Yamano T; Okabe T; Arishiro K; Hoshiga M; Shimizu A; Tsuji M; Hanafusa T
Rinsho Ketsueki; 2006 Jan; 47(1):16-22. PubMed ID: 16479978
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
[TBL] [Abstract][Full Text] [Related]
4. Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Gemmel C; Cremer FW; Weis M; Witzens M; Moldenhauer G; Koniczek KH; Imbach U; Ho AD; Moos M; Goldschmidt H
Ann Hematol; 2002 Feb; 81(2):119-23. PubMed ID: 11907796
[TBL] [Abstract][Full Text] [Related]
5. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
Shindo T; Yumoto Y; Yoshida M; Okuda T
Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
[TBL] [Abstract][Full Text] [Related]
6. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
7. [IgM type multiple myeloma expressing various surface adhesion molecules and demonstrating an aggressive clinical course].
Hirayama Y; Sakamaki S; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Kato J; Niitsu Y
Rinsho Ketsueki; 2003 Sep; 44(9):957-61. PubMed ID: 14577317
[TBL] [Abstract][Full Text] [Related]
8. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
[TBL] [Abstract][Full Text] [Related]
9. [Effective combination chemotherapy with rituximab for acute lymphoblastic leukemia with bone relapse after bone marrow transplantation].
Abe T; Kitajima T; Honma K; Kurasaki T; Okazuka K; Shibasaki Y; Momoi A; Kuroha T; Masuko M; Yagisawa K; Furukawa T; Toba K; Aizawa Y
Rinsho Ketsueki; 2008 Nov; 49(11):1556-61. PubMed ID: 19047788
[TBL] [Abstract][Full Text] [Related]
10. [Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
Iino M; Nakajima A; Shindo H
Gan To Kagaku Ryoho; 2008 Dec; 35(13):2441-3. PubMed ID: 19098420
[TBL] [Abstract][Full Text] [Related]
11. Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation.
Johnson MR; Del Carpio-Jayo D; Lin P; Giralt S; Anderlini P; Champlin RE; Khouri IF; Vadhan-Raj S; Medeiros LJ; Bueso-Ramos CE
Ann Diagn Pathol; 2006 Oct; 10(5):263-8. PubMed ID: 16979517
[TBL] [Abstract][Full Text] [Related]
12. [Acute renal failure in IgM plasmocytoma with hyperviscosity syndrome].
Nitschke M; Fink K; Pawlow-Handt S; Leeker A; Rob PM; Steinhoff J
Dtsch Med Wochenschr; 1997 Oct; 122(40):1213-6. PubMed ID: 9378045
[TBL] [Abstract][Full Text] [Related]
13. [Successful VEP-IFN-alpha therapy in a case of non-secretory plasma cell leukemia (BJ-kappa type)].
Masaki Y; Shimizu S; Takeshita S; Fukutoku M; Yoshioka R; Arai T; Hirose Y; Sugai S; Konda S; Takiguti T
Rinsho Ketsueki; 1994 Jun; 35(6):562-8. PubMed ID: 8078191
[TBL] [Abstract][Full Text] [Related]
14. [Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress].
Makita M; Nakamura K; Kono A
Rinsho Ketsueki; 2005 Nov; 46(11):1196-201. PubMed ID: 16440803
[TBL] [Abstract][Full Text] [Related]
15. Plasma cell leukemia: a rare condition.
Jiménez-Zepeda VH; Domínguez VJ
Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
[TBL] [Abstract][Full Text] [Related]
16. [Plasma cell leukemia (IgA-lambda type) with polyclonal hypergammaglobulinemia].
Hyodo T; Iwamasa K; Nakatani S; Yanagisawa K; Hasegawa H; Yasukawa M; Fujita S
Rinsho Ketsueki; 1998 Sep; 39(9):680-5. PubMed ID: 9796403
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
18. [Plasma cell leukemia presenting with circulating villous lymphocytes and an indolent clinical course].
Saiki M; Saitoh T; Morimoto K; Kumagai T; Tanaka M; Aikawa S; Tsuboi I; Sawada U; Horie T; Amagai M
Rinsho Ketsueki; 2000 Mar; 41(3):186-91. PubMed ID: 10774246
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
Wu Y; Zhang X; Ma X; Suo X; Li R
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
